# ESPRESSO (Epidemiology Strengthened by histoPathology Reports in Sweden)

> **NCT06371820** · — · ACTIVE_NOT_RECRUITING · sponsor: **Karolinska Institutet** · enrollment: 13000000 (actual)

## Conditions studied

- Gastrointestinal Diseases

## Interventions

- **OTHER:** ESPRESSO [The study has no intervention]

## Key facts

- **NCT ID:** NCT06371820
- **Lead sponsor:** Karolinska Institutet
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** ACTIVE_NOT_RECRUITING
- **Start date:** 1965-01-01
- **Primary completion:** 2043-05-17
- **Final completion:** 2043-05-17
- **Target enrollment:** 13000000 (ACTUAL)
- **Last updated:** 2024-04-17


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06371820

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06371820, "ESPRESSO (Epidemiology Strengthened by histoPathology Reports in Sweden)". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT06371820. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*